We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Quotient Clinical showcases Translational Pharmaceutics and RapidFACT at AAPS 2015

Read time: Less than a minute

Held in Orlando, Florida, from the 25th to the 29th of October, this meeting provides attendees with an opportunity to see some of the latest developments in the pharmaceutical sector. Quotient Clinical will be presenting six posters describing projects which have benefited from the reduced costs and shorter development timelines offered by the company’s pioneering Translational Pharmaceutics. 

Quotient will also host the 4th Annual RapidFACT User Group Meeting in Orlando on the 27th of October. Delegates at this event will have the chance to learn more about how this innovative approach is helping pharmaceutical development teams to accelerate drug production optimization. RapidFACT has already been used in hundreds of early development and life cycle management programs, and a number of customers – including Upsher-Smith Laboratories and Stealth BioTherapeutics – will present case studies illustrating how it has enhanced their development projects. This will be followed by a discussion on emerging applications and a complimentary lunch, providing an informal opportunity to network with leading industry figures. 

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.